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Summary
Objectives: Recognising dilemmas posed by the sharing and 
reuse of health data as a classic wicked problem and uncover 
some current key challenges to clinical research informatics.
Methods: A modified thematic review process including identi-
fication of agreed critical research questions, appropriate query 
terms and search strategy, identification of relevant papers in 
accordance with inclusion criteria, and authors’ co-review of full 
text papers.
Results: Queries returned 4,779 papers published between Jan-
uary 2014 and November 2017. A shortlist of 197 abstracts was 
analysed and 18 papers were finally selected for review. The-
matic assessment of findings revealed four key challenges: (1) 
uncertain reliability of consent as a cornerstone of trust due to the 
limits to understanding and awareness of data sharing; (2) ethi-
cal challenges around equity and autonomy; (3) ambitious overly 
theoretical governance frameworks lacking practical validity; and 
(4) a clear desire for further public and individual engagement 
to achieve clearer and more nuanced knowledge dissemination 
around data sharing practice and governance frameworks.
Conclusions: Understanding the wicked problem of reusing 
clinically acquired health data for research purposes is essential 
if clinical research is to benefit from informatics advances. A lack 
of understanding around the context of data acquisition and 
sharing undermines the foundations of patient-professional trust. 
Efforts to protect privacy, where tailoring to specific contexts is 
a key driver, should support the development of solutions which 
more adequately honour privacy needs, justify access, and protect 
equity and autonomy.
Keywords
Clinical research; informatics; privacy; ethics; access and data 
sharing; trust; consent; public engagement and involvement.
Yearb Med Inform 2018:170-6
http://dx.doi.org/10.1055/s-0038-1641219
Introduction
Advances in research capability heralded 
by Electronic Healthcare Records (EHRs) 
and more recently genomics, the Big Data 
paradigm, and richer data gathering through 
personal mobile devices bring to the fore 
new challenges for health data sharing that 
lie between privacy protection and access 
to those data. Appropriate balancing of per-
sonal privacy with the potential benefits of 
health data reuse to improve care represents 
a wicked dilemma. 
In early 2016, an editorial in the British 
Journal of General Practice [1] explored the 
importance of considering the confidential 
therapeutic relationship as the context of 
data acquisition to guide how to govern the 
uses of data for purposes beyond that con-
text of confidence and trust. The primacy of 
the therapeutic relationship helps us to ap-
preciate the essence of the wicked problem: 
it is one of an individual desire for privacy 
which can be set aside when the individual 
chooses to do so – which one controls as 
part of the trusting relationship with his/her 
healthcare provider. But data reuse beyond 
that relationship cedes control to unknown 
others with whom the individual has no 
relationship at the time the individual orig-
inally shared the data. In approaching this 
survey, we have decided to apply this lens 
to develop an understanding of the current 
and evolving challenges.
Nearly two years on, the literature 
re-emphasises how data is becoming 
richer, its capture more personal and more 
revealing. It has also revealed the extent to 
which mechanisms by which the clinical 
research informatics community can assure 
privacy and justify access are not as robust 
as expected or assumed. Whilst public 
awareness is increasing and transparency 
in research and protection are becoming 
more paramount and mandated under an 
international law with the forthcoming 
enforcement of the EU General Data 
Protection Regulation (GDPR) [2], the ob-
jective of this review is to uncover current 
key challenges to clinical research infor-
matics and emphasise how understanding 
of these issues for both data subjects and 
data sharing beneficiaries is a particular 
challenge so that the clinical research in-
formatics community can start to develop 
ways of thinking meaningfully about the 
requirements of solutions.
Methods
As the aim of this review was to survey 
current approaches to the wicked problem 
of appropriate reuse of clinical information, 
the authors adopted a modified thematic 
review approach focused on understanding 
the dilemma space in a pragmatic way in 
order to provide a useful platform to support 
reasoned debate about the development of 
solutions. Neither meta-analysis nor ex-
tensive critique of the shortlisted literature 
formed part of the methodology. Rather, the 
research team focused on the identification 
of a tractable research question within the 
‘wicked’ dilemma space, the development 
of a robust search strategy, data gathering, 
and the synthesis of key findings.
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Research Question and Scoping 
Questions
The authors agreed the core research 
question would focus on the dilemmas in 
balancing privacy and access needs when 
re-using health data for clinical research. 
Inherent in this question is the recognition 
that individuals have many changing roles 
and identities, and that the dilemma goes way 
beyond a binary view of private individual 
vs. public citizen. We agreed to consider 
scoping questions that would help us to 
narrow search terms, query articulation, 
and points of relevance as we retrieved and 
reviewed the literature.
These scoping questions assessed how 
key concepts were understood in the liter-
ature, how well privacy risks and access 
needs were balanced, and the extent to which 
consented or unconsented clinical research 
informatics endeavours had any impact. 
We started by asking “what is understood 
by privacy in the legal, ethical, and societal 
contexts?” and “what is understood by access 
to data shared to support health research?”. 
Questions further included “how are privacy 
needs met and do they honour expectations 
when health data is accessed?”, “how well 
are privacy and access needs balanced in 
health–related research and is there a trade-
off?”, and “what bearing does consented 
and non-consented research have?” to help 
guide our review.
Search Terms 
In considering our research questions and 
focus, we listed a series of query terms re-
lated to the scoping questions and manually 
cross referenced them with MeSH terms. 
We first developed a scoping query that 
would narrow our search for literature on 
MEDLINE to sharing and reuse of data to 
support clinical research informatics that 
included genomics, mobile health, Big Data, 
clinical data warehouses, and repositories 
in scope. We focused on clinical, epidemio-
logical, bioinformatics, omics, cohort, and 
evaluation studies.
In combination with the scoping query, 
we developed queries that were related to pri-
vacy, consent, data protection, information 
security, trust and trusting relationships, and 
ethics. We also agreed that public engage-
ment and involvement were an important 
area to consider in our scoping questions 
given their significance to transparency, 
the understanding of public and individual 
expectations, and trust. These concepts were 
further expanded using indexed and MeSH 
terms, and the final set of terms was agreed 
by each author. These queries are available 
on request.
Paper Selection, Data Extraction, 
and Analysis
The queries were run on MEDLINE on 20th 
November 2017 for manuscripts published 
between 1st January 2014 and 20th November 
2017 in line with the 2018 IMIA Yearbook 
scope for review. In total, 4,779 publica-
tions were returned. Titles were reviewed 
in the first instance to shortlist according to 
their relevance to the scoping and research 
questions, and an agreement was reached on 
which to discard. No language restrictions 
were placed on publications as the authors 
were prepared to seek translators to help 
translate the papers or a translation may have 
been otherwise available online, though no 
publication fell into this category.
Of the 197 manuscripts shortlisted for 
review on the abstract, it was agreed that 
the full text article of 18 of the manuscripts 
should be reviewed. For the first stage of 
manuscript selection, the lead reviewer (NL) 
screened articles based on titles and abstracts 
and only eliminated articles clearly not rel-
evant to the research question. The authors 
also agreed that the cyber / information 
security manuscripts retrieved in particular 
appeared predominantly to be descriptive of 
technical solutions tested in vitro and provid-
ed little insight for the research questions.
After the identification and removal of 
duplicates, all reviewers independently 
screened titles and abstracts against the 
inclusion criteria to identify potentially rel-
evant papers. Articles identified for potential 
inclusion by the three reviewers were obtained 
and a final assessment was made by two 
authors to confirm their eligibility. Con-
sensus between the reviewers was reached 
by discussion and a final list of articles to be 
read in detail was made. Where there was 
disagreement between authors, the authors 
agreed they would go with the majority view, 
though no disagreement arose.
The manuscripts selected for potential 
inclusion were divided and assigned to each 
author. At least two authors reviewed each 
of the manuscripts independently to extract 
data and confirm relevance to the research 
questions. Then, authors reviewed the data 
and agreed on findings. 
To minimise the risk of bias, data were 
extracted using a structured approach that 
included the following information: methods, 
study design, duration, and setting; aims and 
inclusion criteria; number of participants 
eligible, included, and evaluated; participant 
characteristics (age, gender, career stage); 
outcomes on which authors collected mea-
surements, including qualitative evidence 
analysis of participant views where we will 
report results relevant to this review; and notes 
on any important limitations of the study.
In synthesising results from the data, 
we drew broadly on methods for thematic 
research described by Thomas and Harden 
[3]. Qualitative data was extracted and the 
main findings grouped together in order to 
identify themes which reflect similarities 
and differences in content to identify the key 
dilemmas for health data reuse in clinical 
research informatics. 
Results
We describe the 18 papers that were reviewed 
in detail. The findings from the data anal-
ysis have been grouped into the following 
five themes to identify the key dilemmas 
for sharing health data to support clinical 
research. These include Ethical Concerns, 
Consent and Control, “Hamstrung” Trust: 
Low Awareness vs. Appetite to Learn and 
Engage, Legal and Practical Concerns, and 
Societal Values.
Ethical Concerns
De Lusignan et al. use their literature review 
and consensus building approach to develop 
a framework to honour privacy and ethical 
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concerns around data access [4] where they 
identify the challenges in bringing together 
enough experts with the capabilities to 
honour the requirements of the ethical 
framework. From the ethical perspective, 
they promote a series of questions derived 
from Willison et al.[5]. These questions 
focus on identifying potential burdens and 
harms and who must bear them and wheth-
er they are justified, whether participant 
selection is fair and appropriate, whether 
informed consent is warranted and feasible, 
what level of engagement is appropriate and 
what the social implications are of the data 
access, and what the potential longer-term 
consequences are.
Research facilitated by mobile apps raise 
the profile of ethical concerns around data 
sharing. Moore et al. [6] identify concerns 
about whether fundamental ethical principles 
as espoused in the Nuremberg Code are be-
ing followed across the board. App-mediated 
research poses a unique risk to privacy which 
participants may not be aware of (e.g. around 
GPS data use). This is a point that was also 
picked up by Nebeker et al. who reported that 
participants were concerned about wearing 
devices that could track their locations along 
with concerns about impacts on lifestyle 
privacy and security [7].
Arora et al. further illustrate the ethical 
concerns with the issues of limited under-
standing of technology used for mHealth 
research. They highlight that if people don’t 
understand the technology they won’t be able 
to meaningfully grasp the risks versus ben-
efits. Since it takes time to help educate and 
develop awareness, mobile health research-
ers should focus on developing systems that 
enhance participant privacy [8].
Consent and Control
Nebeker et al. emphasise that “creating a 
meaningful informed consent process is crit-
ical and will likely require involving partic-
ipants as partners who are willing to review 
and modify consent language and processes 
to increase access and understanding” [7].
The qualitative study performed by 
Spencer et al. [9] illustrates the nuances of 
consent where participants did not talk about 
the time varying nature of consent, but rather 
spoke about the value of using the dynamic 
consent system to make a one-off decision 
if they wanted to opt-out. 
Dynamic consent also features in the dis-
cussion piece by Williams et al. [10], which 
recognises that dynamic consent implies an 
e-Infrastructure and whilst it may provide a 
portal for research participants to consent or 
revoke consent, it does not provide an ethical 
framework to account for variances in rights, 
needs, and understanding of participants.
This raises a key issue around consent 
related to the points raised by Arora et al. 
[8] which is also illustrated in the qualitative 
study performed by Audrey et al. [11] that 
identifies uncertainties around effectiveness 
of anonymisation. This causes further doubt 
around the validity of informed consent as 
a cornerstone of good governance and the 
extent to which research participants un-
derstand different types of consent and what 
they are/are not consenting to.
Big Data supported health research 
casts further scrutiny on consent: Rothstein 
recognises consent as being something that 
shows respect for autonomy and dignity of 
the individual, despite citing other work that 
consent for Big Data is too expensive and 
that consent is fetishised. He argues that 
a robust opt out is ethically equivalent to 
opt in and that ticking an opt out box is no 
different than ticking an opt in box in terms 
of effort [12].
Balas et al. in their literature review of 
Big Data clinical research identify public 
concerns around the reuse of data in terms 
of security and a preference for research on 
aggregate data only. They find that reuse 
by clinical professionals and others for the 
benefit of others (i.e. community health) 
directly impacts autonomy whether partic-
ipants would have consented or not. They 
emphasise that confidentiality is a mandate 
to protect anything shared in a trusting re-
lationship, but that this can be overridden if 
sharing the data mean benefits for society 
that outweigh the individual’s interests in 
keeping it private [13]. 
In the systematic review by Aitken et 
al. [14] that focused on public responses 
to health data sharing and linkage, a large 
number of studies were identified reporting 
that assurances of individuals’ confidenti-
ality were crucial for public supporting the 
reuse of health data for research. This was 
largely associated with anonymisation of 
data, although the review notes that ano-
nymisation was not an absolute guarantee 
of confidentiality. The review also reported 
a recognition that the anonymisation pro-
cess is imperfect and does not adequately 
protect privacy.
Autonomy and control were identified in 
the review as key factors, but there was no 
clear consensus found on what the control 
looked like. Respondents also wanted to 
strike a balance between control and efficien-
cy of research, where consent was seen as a 
key requirement for research acceptability, 
but there was some acceptability for practi-
cality and not to hinder research.
Grande et al. [15] highlight the impor-
tance of purpose and make the point that 
whilst consent is emphasised in research, 
it is important to consider purpose as well 
because that has a great deal of impact on 
people’s opinions.
“Hamstrung” Trust: Low Awareness 
vs. Appetite to Learn and Engage
Discussions around consent and participa-
tion must be considered while taking into 
account the identified low awareness of data 
sharing and use. Spencer et al. highlight that 
participants reported low levels of aware-
ness of how their personal information is 
stored and shared for research where there 
was some fear of the unknowns, and whilst 
patients were supportive of sharing their 
anonymised EHR for research, they noted a 
lack of transparency and awareness around 
the use of the data making it difficult to 
secure public trust [9].
The systematic review from Aitken et 
al. also point to a discernible appetite for 
more information around research and its 
governance. Assurances of safeguards were 
identified as essential for support but there 
was low awareness of the research practice 
and ethical processes in place. Knowledge 
about what was involved with research helps 
to increase acceptance [14].
The findings by Nebeker et al. in the 
context of mobile apps add further weight 
to the need to properly engage with partici-
pants and for efforts to educate individuals 
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so that they can develop an improved ability 
to make informed decisions around studies 
that involve mobile sensing technology. 
Such education about technologies used 
in research “can reduce barriers associated 
with a lack of familiarity and, subsequently, 
increase trustworthiness of the research 
enterprise” [7].
Legal and Practical Concerns
There are numerous examples of guidelines 
and codes of practice around legal and 
practical good practice, perhaps reflecting 
both the inherent wickedness of the space 
as well as deficiencies both in the current 
articulation and use of law and of its role in 
addressing a wicked issue. De Lusignan et 
al. provide a set of practical questions from 
their consensus work for data protection, 
focusing on identifying responsibility for 
the accountability of the data and where it 
will be stored, who will have access to it, 
whether there is an audit trail to indicate 
the data were legally obtained, whether it 
is sufficiently anonymised, restrictions for 
secondary processing of the data, whether 
their accuracy be verified and any processing 
is documented, and whether individuals can 
opt out of its processing [4].
Eagleson et al. define an 11-point set 
of guidelines derived from literature per-
taining to information security assurance 
mechanisms, including authentication, 
audits, access controls based on roles and 
patient preferences by way of consent, and a 
patient-controlled privacy policy [16]. They 
also highlight how transparency can keep 
researchers accountable and that sharing 
security dilemmas and solutions can help 
to keep projects from having to implement 
the same security mechanisms from scratch.
A qualitative study by Shabani et al. 
provides insight into concerns around the 
practical and legal considerations in the US. 
The study conducted interviews and presents 
responses from data access regulators (Data 
Access Controllers or DAC). The study rais-
es key points about practical challenges for 
managing access to data [17], in particular, 
the study questions the adequacy of access 
reviews which look at whether access should 
be granted for processing.
Qualifications of applicants to process 
data are assessed but the checks are incon-
sistent and have a “low bar” where the qual-
ification criteria are fragmented or poorly 
defined. This involves “googling” applicants 
and requesting numbers of publications, but 
this is only to check their affiliation with 
an organisation. The study raises the point 
of a bona fide researcher but reports that 
what this means is not clear. Nebeker et al. 
also point out that “those who donate their 
data for research probably expect that the 
research will be carried out by those with 
demonstrated competence in the field” [7].
DACs discussed the monitoring of the 
uses of data once accessed. However, this 
is limited to checking on publications and 
intellectual property registrations, while they 
can request reports from data accessors, but 
this is hard to regulate since there are many 
international collaborators. The overriding 
point was the study “...showed the DAC 
members and experts are ambivalent about 
the effectiveness and consistency of the cur-
rent access review procedures, and oversight 
process...”.
Sanctions were identified as important but 
there is no professional code that governs 
researchers. The DACs favour Codes of 
Practice where sanctions could be specified 
and they feel that holding the employer 
responsible for the activities of his/her staff 
would provide an appropriate basis to apply 
sanctions.
Aitken et al. identified in their systematic 
review that security was an important factor, 
where fallibility of IT systems and human 
errors are understood to be key risks. There 
appears to be a tolerance for security risks 
that participants identified as always being 
possible because they also valued the bene-
fits of research [14].
Genomics research also raises particular 
concerns around security. Wang et al. in the 
US illustrate that genomic data for which 
identifiers have been removed is unprotect-
ed, yet re-identification risks are significant. 
De-identified data are often obtained using 
cursory broad consent but these risks can 
clearly increase as more ‘side’ data become 
accessible. Risks are therefore not communi-
cated and are not static so re-identification risk 
increases with both technological advances 
in linkage plus increased knowledge about a 
specific individual offering a more complete 
picture. This is illustrated by the work of 
Gymrek and colleagues who managed to 
identify several male participants of the 1000 
Genomes Project using their Y-chromosome 
markers, their family structure, and online 
genetic genealogy databases [18].
Societal Values
Liyanage et al. [19] identify an increased risk 
to privacy inherent with the increased use of 
data from multiple sources and they illustrate 
the risks to privacy that need to be balanced 
with the benefits of data sharing. They work 
towards the development of a privacy and 
ethics framework to help strike a balance 
between those risks and the right to a higher 
attainable level of health. They recognise the 
legitimate concerns of citizens to protect their 
ethics and privacy where their health data is 
used to improve health sector performance.
The systematic review by Aitken et al. 
[14] identified concerns of misuses and 
proliferation of data to third parties and for 
surveillance, with lower concern over polit-
ical use. There were concerns over stigma 
and discriminatory treatment and insurance 
premium issues for research participants, 
but they found that private company uses 
and profitability were acceptable if it was for 
the public good. Many studies reported that 
concerns to personal privacy were balanced 
with the recognition of the importance of 
societal benefits anticipated. Two studies 
reported that some participants prioritised 
societal benefits over personal privacy. 
Spencer et al. found that 98% considered 
the altruistic benefits of sharing data out-
weighed the risks of data falling in wrong 
hands [9]. Additionally, they emphasise the 
importance of trust, finding that most partic-
ipants felt confident NHS Trusts manage re-
cords securely and anonymity was preserved 
when data was used for research. A majority 
expressed satisfaction towards governance 
arrangements in the UK NHS but acknowl-
edged no system can be completely secure. 
A small minority described concerns about 
risks to their privacy speculating that those 
with more sensitive health conditions may 
be more guarded with what happens to their 
health information. 
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Discussion
Table 1 summarises the challenges the re-
view has uncovered related to the themes 
that the review identified and the solutions 
we propose for how to tackle them based on 
the review and developments, particularly 
around preparations for the new General 
Data Protection Regulation in the European 
Union (GDPR).
Table 1   Summary of challenges and proposed solutions
Item 
no.
1.
2.
3.
4.
5.
6.
7.
8.
9.
Challenge identified in literature
Are fundamental rights protected, particularly if participants 
are unaware of the risks involved where they don’t understand 
the underlying technology (e.g. location data and privacy)?
Are there enough experts to oversee ethical concerns and 
dilemmas, particularly as data reuse and management 
increase and evolve? 
Meaningfulness of consent if participants do not understand 
what they are consenting to.
Purpose of data reuse is not always clear and awareness of 
reuse is limited
Demonstrating accountability and transparency around data 
reuse in a provable and clear manner
Competence of data users as a means to demonstrate 
trustworthiness and assure compliance
Reliability of anonymity is more limited than often expected, 
particularly given it has been proven false 
Risks to privacy are often more severe than expected, 
particularly with regards the fallibility of IT systems and where 
more data sets are processed for reuse purposes 
Some contexts, particularly where sensitive health issues are 
concerned, carry greater anxieties around privacy and more 
reluctance to participate.
Theme 
Ethical Concerns
Ethical Concerns
Consent and Control / 
“Hamstrung” Trust
Consent and Control / 
“Hamstrung” Trust
Legal and Practical
Legal and Practical
Consent and Control / 
Legal and Practical / 
“Hamstrung” Trust
Societal Values
Societal Values
Proposed solutions
Engagement with participants and ensuring they understand the nature of the 
research and new technologies being studied.
Share ethical oversight with greater reliance on informed and engaged 
professionals and lay representations (see item 6 below).
Closely follow the developments for GDPR preparation across EU, particularly with 
regards appropriateness of consent as a legal basis for processing data where 
other bases may be more appropriate; where consent is sought to participate in 
research data reuse must be understood, particularly with regards transparency.
Ensure that engagement with participants and public clearly articulates purposes 
and benefits in a way that can be understood and challenged, as required by 
GDPR for transparency; be clear on the rights of participants, particularly with the 
new GDPR requirements.
GDPR now requires proof of compliance and accountability as well as transparency 
with regards data use so preparations to support this are key to handling these 
challenges within and outside the EU. Approval mechanisms must be rigorous and 
must be independently verifiable, and should always be transparent.
Training and education around data protection must focus more on contextual 
understanding and less on “tick-box” learning, where understanding must 
be demonstrated in line with GDPR and other developments; assessment of 
competence must also have formal, independently verifiable processes that are 
clearly defined and transparent. 
Claims around anonymity of datasets must be verified more clearly and should 
take into account the context of data processing and the time-limited nature of 
anonymity.
Clearly articulate the risks involved so individuals can make an informed decision 
about balancing their contribution to societal benefits and risks against their own 
privacy and wellbeing. Ensure preparations for GDPR compliance are in line with 
its requirements around transparency and accountability for handling data, and its 
emphasis on the need for security.
Understand the context of data acquisition and reuse, and ensure the concerns and 
anxieties of the studied population are taken into account. 
The review has highlighted some of the 
challenges for sharing and reusing health 
data across the evolving landscape of clinical 
informatics research which can be distilled 
into four key challenges: (1) uncertain reli-
ability of consent as a cornerstone of trust 
due to limits to understanding and awareness 
of data sharing; (2) ethical challenges around 
equity and autonomy; (3) ambitious overly 
theoretical governance frameworks lacking 
practical validity; and (4) a clear desire for 
further public and individual engagement to 
achieve clearer and more nuanced knowl-
edge dissemination around data sharing 
practice and governance frameworks.
The challenges we have identified are 
not new concepts but the landscape has in-
creased in complexity and uncertainty with 
the advances in omics and mobile health re-
search, and even key messages with regards 
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to using basic EHR data for research are not 
getting across. A recurrent theme was that 
our ability to share data has outstripped our 
ability to clearly and appropriately artic-
ulate ways of managing it. An analysis by 
van Staa et al. highlights the importance of 
transparency, public involvement, evidence 
of credible science and clear benefit, and 
public confidence that data is held securely 
and appropriately anonymised are critical to 
the success of Big Data research [20]. 
These points are consistent with our 
findings across the spectrum of clinical 
research informatics, but we propose that 
the lack of understanding around health data 
sharing, lack of clarity on what people are 
consenting to and the resulting problems in 
earning individual trust lie at the heart of the 
wicked problem. For this reason, we elected 
to review the literature with a high-level lens, 
focused as it is on the relationship of trust 
between the private individual and healthcare 
providers when the individual chooses to 
relinquish some of that privacy.
The review returned several publications 
that claim to handle technical security issues 
that threaten privacy, propose methods to 
limit risks to privacy and provide a basis 
for offering other technical or procedural 
solutions, but do not take into account the 
problems of consent and understanding 
risks in context, particularly with respect to 
genomics. This represents a significant eth-
ical challenge in terms of there being a very 
strong case for participants to be informed. 
The review recognises that the threats to data 
security vary according to context and data 
type, and highlights the special issues raised 
by the integration of genomic data. 
Rather than focussing on which consent 
mechanisms are most favoured by the public, 
it may be more valuable to focus on how 
relationships are built up (and conversely 
eroded) and how trust can be facilitated 
within research and data reuse through data 
linkage processes including through public 
engagement and involvement. Studies over-
whelmingly suggest an appetite for more 
information about current research practices 
and uses of data. The public should not be 
conceived only as subjects of information 
provision but there remains a public interest 
and enthusiasm for more meaningful forms 
of public engagement or involvement.
With the new GDPR coming into force 
across the European Union and garnering 
wider international interest, the clinical 
research informatics community now has 
a mandatory goal but also an opportunity 
to tackle some of the wickedness. GDPR 
enhances the need for transparency and 
meaningful dialogue around data processing 
with data subjects, a better understanding of 
the role of consent in research, and offers 
the basis for a more meaningful discussion 
with participants based on new and clearer 
rights. Those who rely on data sharing should 
embrace these as opportunities and prepare 
to be more accountable for their practices as 
guided by the regulation and engage more 
meaningfully and more publicly. This will 
go a long way in navigating the problem 
between sharing data and advancing care 
through clinical research informatics.
We suggest that our findings are the basis 
for a much-needed full systematic review 
aimed at gaining further traction on devel-
oping a far more nuanced understanding 
of the wicked problem(s) we are grappling 
with than has hitherto been the case. It seems 
reasonable that this be performed after 
GDPR has been enforced, as this is likely 
to have an impact on our understanding of 
the challenges and how they can be handled. 
It further seems pertinent to incorporate 
changes in protocols, attitudes, concerns, 
and security risks as genomics research 
continues to thrive.
Conclusions
The review has spotlighted some key dilem-
mas that need to be addressed by the clinical 
and health informatics community. Whilst 
elaborate security and ambitious ethical 
frameworks exist, there remains a lack of 
understanding and knowledge for patients 
which undermines the ethical basis under 
which such frameworks operate. 
Without real transparency or understand-
ing, trust is harder to earn, and despite a 
recognition of the importance of consent 
and confidentiality, consent cannot be the 
cornerstone of trust if people do not under-
stand what they are consenting to and cannot 
meaningfully assert control over what they 
choose to share when they subsequently and 
inadvertently relinquish it later on without 
their knowledge.
No one perspective – be it technical, le-
gal, societal, or ethical– holds the answer to 
this wicked problem. It is a combination of 
perspectives that we have focused on so that 
we can start to understand how to make the 
data sharing problem less wicked.
Clinical research informatics advances 
rely on tackling the wicked problems of 
data reuse. A lack of understanding around 
the context of data acquisition and sharing 
undermines the foundations of trust and 
attempts to protect privacy, but there is how-
ever a clear public enthusiasm to learn more 
about the research technologies and gover-
nance, and to engage with the endeavours. 
This, with the additional legal requirements 
of GDPR and the challenges set by the new 
advances in genomics research, provides an 
opportunity for enhanced collaborations be-
tween agencies and an engagement tailored 
according to specific contexts and individ-
ual needs so that the research community 
will learn to honour personal privacy more 
meaningfully and effectively, justify access 
with more transparency and detail, and better 
protect equity and autonomy.
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